Standard BioTools Inc’s recent filing unveils that its Former Officer Black Jeffrey G. acquired Company’s shares for reported $0.12 million on Nov 12 ’24. In the deal valued at $2.12 per share,57,971 shares were bought.
Then, Taich Adam bought 45,851 shares, generating $91,725 in total proceeds.
Before that, Casdin Partners Master Fund, L bought 250,000 shares. Standard BioTools Inc shares valued at $546,750 were divested by the Director at a price of $2.19 per share. As a result of the transaction, Casdin Partners Master Fund, L now holds 54,025,821 shares, worth roughly $84.82 million.
TD Cowen initiated its Standard BioTools Inc [LAB] rating to a Buy in a research note published on April 16, 2024; the price target was $3.50. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. KeyBanc Capital Markets began covering LAB with “an Overweight” recommendation on July 12, 2023.
Price Performance Review of LAB
On Monday, Standard BioTools Inc [NASDAQ:LAB] saw its stock fall -4.85% to $1.57. Over the last five days, the stock has lost -11.30%. Standard BioTools Inc shares have fallen nearly -10.29% since the year began. Nevertheless, the stocks have fallen -32.91% over the past one year. While a 52-week high of $3.04 was reached on 01/15/25, a 52-week low of $1.21 was recorded on 01/27/25. SMA at 50 days reached $1.8168, while 200 days put it at $2.0399.
Levels Of Support And Resistance For LAB Stock
The 24-hour chart illustrates a support level at 1.5283, which if violated will result in even more drops to 1.4867. On the upside, there is a resistance level at 1.6333. A further resistance level may holdings at 1.6967. The Relative Strength Index (RSI) on the 14-day chart is 39.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1668, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.61%. Stochastics %K at 9.24% indicates the stock is a buying.
How much short interest is there in Standard BioTools Inc?
A steep rise in short interest was recorded in Standard BioTools Inc stocks on 2024-12-31, dropping by -0.24 million shares to a total of 13.52 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 13.77 million shares. There was a decline of -1.8%, which implies that there is a negative sentiment for the stock.
